메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

전체기사

United Imaging Healthcare North America Welcomes John Campbell as Vice President of Customer Success

HOUSTON, Feb. 4, 2026 -- United Imaging, a global leader in advanced medical imaging and radiotherapy solutions, is pleased to announce that John Campbell recently joined the organization as Vice President of Customer Success, North America. In this role, he will support United Imaging's continued growth by strengthening customer partnerships, advancing service excellence, and ensuring long-term value delivery across the installed base. John brings more than 25 years of experience in the healthcare and medical imaging industry, with a career spanning military service, field operations,
- 김갑성 기자
- 2026-02-04 01:00
Guoen Technology Advances Toward Dual Listing with Hong Kong IPO, Sets Final Offer Price at HK$36

HONG KONG, Feb. 3, 2026 -- On January 15, Qingdao Guoen Technology Co., Ltd. (SHE: 002768) announced that it has successfully passed the hearing of the Hong Kong Stock Exchange (HKEX) Main Board, marking a significant milestone in its pursuit of a dual listing on both the Shenzhen and Hong Kong stock exchanges. The company's H-share initial public offering (IPO) will be exclusively sponsored by China Merchants Securities International. According to the updated prospectus and official announcement dated February 3, Guoen Technology has finalized the issue price of its H-shares at HK$36.
- 황정호 기자
- 2026-02-03 22:41
CIMG Inc. announced the signing of computing power equipment sales contracts totaling approximately $2 million

HONG KONG, Feb. 3, 2026 -- CIMG Inc. ("CIMG" or the "Company") (Nasdaq: IMG), a business group specializing in digital health and sales development, which utilizes technologies and marketing networks to enhance its business partners' sales growth and commercial value, today announced that its subsidiary, Beijing Xinmiao Shidai Technology Development Co., Ltd. has entered into five sales contracts for computing power hardware equipment with multiple companies, including Guangzhou Liangjingjing Technology Co., Ltd., Tianjin Herunsheng Technology Development Co., Ltd., Tianji
- 황정호 기자
- 2026-02-03 22:20
Metabolon Names Andrew Messick Chief Financial Officer

Seasoned life sciences finance leader brings deep expertise in operational excellence and M&A to support Metabolon's next stage of growth MORRISVILLE, N.C., Feb. 3, 2026 -- Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic development, and precision medicine applications, announces the appointment of Andrew (Drew) Messick as Chief Financial Officer. "Drew brings more than 25 years of financial leadership experience, with a proven track record of driving growth through
- 김갑성 기자
- 2026-02-03 22:00
Akso Health Group Announces Launch of Exploratory Global Patient Support Initiative

QINGDAO, China, Feb. 3, 2026 -- Akso Health Group (NASDAQ: AHG) ("Akso Health" or the "Company") today announced the launch of the an exploratory patient support program and a strategic cooperation with Nanning Duoling Research Institute. Adopting an integrated model of "Traditional Chinese Medicine (TCM) practice + modern medical technology", certain medical resources will be coordinated and integrated to provide free in-hospital treatment plans for up to 10,000 eligible patients within participating medical institutions. The patient support program directly add
- 황정호 기자
- 2026-02-03 22:00
Insilico Medicine Receives USD 5million Milestone Payment from Menarini Group Following First-in-Human (FIH) Achievement for MEN2501

[ 메디채널 김갑성 기자 ] Followed by the development and regulatory milestone payment of USD 3 million in July 2025, Insilico received an additional milestone payment of USD 5 million from Menarini Group after first-in-patient dosing in a Phase 1 trial of MEN2501, highly differentiated small molecule KIF18A inhibitor in development for chromosomally unstable solid tumors designed using Insilico's generative AI engine. CAMBRIDGE, Mass., Feb. 3, 2026 -- Insilico Medicine ("Insilico"), a clinical-stage, generative artificial intelligence (AI)-driven biotechnology company, today announc
- 김갑성 기자
- 2026-02-03 22:00
NYSE Content Advisory: Pre-Market Update + AstraZeneca Climbs Nearly 1% After Historic NYSE Transfer

NEW YORK, Feb. 3, 2026 -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. NYSE Content Advisory: Pre-Market Update + AstraZeneca Climbs Nearly 1% After Historic NYSE Transfer Ashley Mastronardi delivers the pre-market update on February 3rd Stocks are mixed as investors track a heavy week of corporate earnings — including reports from NYSE‑listed Pfizer, Eaton, Uber, and Eli Lilly — while labor data is disrupted by
- 황정호 기자
- 2026-02-03 21:58
Newmark、2026年ソウルオフィス市場見通しを発表、ファンダメンタルズの強化を強調

[ 메디채널 황정호 기자 ] 22.9兆ウォンという記録的な回復の後、ソウルオフィス市場は構造的再配置の段階に入るニューヨークとソウル（韓国）, 2026年2月3日 --Newmark Group, Inc.（Nasdaq: NMRK）（"Newmark"）はグローバル企業、機関投資家、オーナーおよび入居者向けの大手商業不動産アドバイザー兼サービスプロバイダーです。Newmarkは本日、2026年ソウルオフィス市場見通し（資本市場およびリース部門）を発表し、急速に回復する資本市場環境とともに堅調な入居者市場を強調しました。経営陣からのコメント「ソウルのオフィス市場は、入居者市場、資本市場ともに基本的に底堅く推移しています」と、Newmark Koreaのマネージングディレクター兼カントリーヘッドであるJohn Pritchardは述べています。「企業や投資家がより質の高い、より効率的な資産に注目する中、需要の戦略的な再配分が見られます。テナントの需要は、一等地や新しく開発されたオフィスへの集中が進む一方、老朽化したストックは競争圧力の高まりに直面しています。」 Judy Jang（エグゼクティブディレクター、韓国担当のリサーチ部門責任者）は、「2025年に記録的な22兆9,00
- 황정호 기자
- 2026-02-03 21:53
Locksley Announces High-Grade Antimony Results from Batch Sampling Program at its Mojave Project

SAN BERNARDINO, Calif., Feb. 3, 2026 -- Locksley Resources Limited (ASX: LKY; OTCQX: LKYRF; OTCQX ADR: LKYLY) announced that a batch sampling program at the DAM antimony (Sb) deposit, part of the Mojave Project in California, returned high grade antimony results. The batch sampling program, which was designed to further evaluate the high-grade antimony mineralization at DAM following technical milestones achieved in late 2025, including a 325kg sample and the production of a 68.1% Sb premium concentrate, targeted specific mineralized vein material within the historical workings. Detai
- 황정호 기자
- 2026-02-03 21:42
GROUP OF CHAARAT GOLD NOTEHOLDERS RESPOND TO REDEMPTION PROPOSAL

LONDON, Feb. 3, 2026 -- A group of holders (the "Group") of the Senior Secured Convertible Loan Notes due 2028 (the "Notes") issued by Chaarat Gold Holdings Limited ("Chaarat Gold") responds to the notice from Chaarat Gold that it intends to redeem the Notes in full on 13 February 2026 from the proceeds of sale of its equity interest in Zaav Holdings Ltd to SilverCorp Metals, Inc (the "Sale"). The Group is supportive in principle of any legitimate transaction that results in timely repayment of the Notes (and realisation of value for Chaarat Gold
- 황정호 기자
- 2026-02-03 21:31

이전

61 62 63 64 65 66 67 68 69 70

많이 본 기사

최근기사

2026-03-02_MON

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2026년 03월 02일 23시 40분